+987.9%
MRNA vs ELV
+42.6%
+945.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ELV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.9% | +8.2% | +11.6% |
| 7D | +20.6% | +4.8% | +15.9% | +19.1% |
| 30D | +27.1% | +10.1% | +17.1% | +23.4% |
| 3M | +353.4% | +15.4% | +338.0% | +334.5% |
| 6M | +446.3% | +17.7% | +428.5% | +416.0% |
| YTD | +776.2% | +25.7% | +750.5% | +685.8% |
| 1Y | +987.9% | +39.9% | +948.1% | +796.5% |
| All | +987.9% | +42.6% | +945.3% | +796.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ELV.
Daily Out/Under-Performance
Portfolio return minus ELV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ELV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ELV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling